Article Details
Retrieved on: 2022-10-17 18:18:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Only one of the clinically available monoclonal antibody treatments that were tested, bebtelovimab, was able to potently neutralise the new ...
Article found on: www.news18.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here